Levosimendan concentrate for preparation of solution for infusions 2.5 mg/ml in 5 ml;Lornoxicam, powder/lyophilisate for solution for injection, 8 mg each;Blood coagulation factor IX, II, VII and X in combination, powder for solution for infusions, 500 IU each;Urapidil solution for injection 5 mg/ml in 5 ml;Urapidil solution for injection 5 mg/ml in 10 ml;Combinations (18.75% glucose solution with calcium - 600 ml; 6.3% amino acid solution with electrolytes - 600 ml; 15% lipid emulsion - 300 ml)
By: Lyudmila Romanchuk📍 UkraineOpen
Key Information
| Reference | GB-UA-2026-11-12-014047-a |
|---|
| Deadline | Nov 17, 2026 12:00 AM |
|---|
| Estimated Value | UAH 230,444,700.00 |
|---|
| Category | Advertising & Media |
|---|
| Competition Type | ICB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | Ukraine |
|---|
| Address | 33027, Ukraine, Rivne region, Rivne, st.Kyivska, 78 |
|---|
| Published | Nov 12, 2026 |
|---|
Description
Levosimendan concentrate for preparation of solution for infusions 2.5 mg/ml in 5 ml;Lornoxicam, powder/lyophilisate for solution for injection, 8 mg each;Blood coagulation factor IX, II, VII and X in...
Full details are available after unlocking this tender.